BioSpace News Archive

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has provided $1.2 million in additional funding to U.S and international organizations to support COVID-19 relief efforts, including: The Chicago Community Trust, The Lake County Community Foundation, Silicon Valley Community Foundation, Greater Washington Community Foundation, Americares, ALONE, Family Carers Ireland, Enable Ireland and Toronto Foundation.

MedX Health Corp. (“MedX” or “Company”) (TSX-V: MDX) announced its results for the three and nine-months ended September 30, 2020, which are also available on SEDAR (www.sedar.com).

Fire Monkey version 8 (FMv8) record-breaking 30Gb+ yield of raw DNA data from an E. Coli sample on a single Oxford Nanopore Technologies (ONT) MinION flow cell

Validant, a leading transatlantic quality, compliance and regulatory consulting group (‘the Group’), has acquired IDEC, a leading regulatory consultancy in Japan. IDEC supports customers from across the globe and helps them navigate the Japanese market by providing strategic advice and hands-on implementation support.

Ovation Science Inc. is pleased to announce that its DermSafe® Hand Sanitizer Lotion is now available in select locations of Source For Sports, a Canadian sporting goods retailer with over 130 locations across Canada.

- FDA Grants Priority Review and Sets PDUFA Date of May 30, 2021 - - Application Being Evaluated Under FDA;s Real-Time Oncology Review (RTOR) and Project Orbis Pilot Programs -

Testing to inform national research to assess impact of COVID-19 on racial minorities and underserved communities across the country

Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) has obtained a positive decision confirming that the Swedish Tax Agency shares the Company’s assessment that the Company’s proposed distribution of the shares in OncoZenge qualifies as a Lex Asea distribution in accordance with chapter 42, section 16 of the Income Tax Act, whi

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the unveiling of its new C360™ cervical spine portfolio, including the commercial launch of the Anterior Cervical Plating (ACP) system

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for zanidatamab in patients with previously-treated HER2 gene-amplified biliary tract cancer (BTC).